The pyrogen testing market expanded as a result of increased investments in R&D made by the pharmaceutical and biotechnology sectors. Pharmaceutical, biotech, and other drug manufacturing companies use pyrogen testing to ensure the safe production and release of infection-free products onto the Pyrogen Testing Market.
For instance, major pharmaceutical market players Roche, AstraZeneca, and Merck all made significant R&D investments in 2019. Roche spent about $12 billion on investments, which accounted for 19% of its $63.3 billion in sales. As a result, the pyrogen testing market is driven by pharmaceutical companies' substantial investments in research and development.
Read More:
https://knackersblogger.blogspot.com/2022/12/pyrogen-testing-market-size-share.html
